Status:
COMPLETED
Research Tissue Bank
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
Myeloproliferative Disorders-Research Consortium
National Cancer Institute (NCI)
Conditions:
Myelofibrosis
Idiopathic Myelofibrosis
Eligibility:
All Genders
18+ years
Brief Summary
This study that will allow for the preservation and/or storage of a small portion one or more of the following tissues: * Peripheral blood * Bone marrow * Bone marrow biopsy * A phlebotomized unit of...
Eligibility Criteria
Inclusion
- Patients diagnosed with Philadelphia chromosome negative myeloproliferative disorders (MPD) polycythemia vera (PV), idiopathic myelofibrosis (IM), and essential thrombocythemia (ET) are eligible.
- Newly diagnose MPD patients as well as previously treated for a MPD are eligible.
- Signed informed consent is required from each patient at the time of enrollment.
Exclusion
- Patients currently participating in experimental treatment arms of MPD-RC protocols, or other experimental treatment protocols are not eligible during the period they are on study.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 27 2017
Estimated Enrollment :
963 Patients enrolled
Trial Details
Trial ID
NCT00666549
Start Date
September 1 2007
End Date
March 27 2017
Last Update
July 5 2019
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Palo Alto Medical Foundation Research Institute
Palo Alto, California, United States, 94301
2
Weill Cornell University
Washington D.C., District of Columbia, United States, 10065
3
University of Georgetown
Washington D.C., District of Columbia, United States, 20057
4
University of Illinois at Chicago
Chicago, Illinois, United States, 60612